In a preview of Anthem's investor day on Thursday, Stephens analyst Scott Fidel noted that the company's long-term adjusted EPS growth target of 8%-12% has been the most conservative among all of the publicly traded managed care companies in recent years. Given that he expects the company to achieve about 16% EPS growth through 2021 based on "several powerful unique tailwinds," Fidel sees the event as an opportunity for the company to update its long-term outlook for EPS growth. He maintains an Overweight rating and $350 price target on Anthem ahead of tomorrow's investor meeting.